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Abstract: 
Neurotoxicity due to excessive brain manganese (Mn) can occur due to environmental (air pollution, soil, 
water) and/ or metabolic aberrations (decreased biliary excretion). Manganese is associated with oxidative 
stress, as well as alterations in neurotransmitter metabolism with concurrent neurobehavioral deficits. Based on 
the few existing studies that have examined brain regional [Mn], it is likely that in pathological conditions it can 
reach 100–500 μM. Amino acid (e.g. aspartate, glutamate, taurine), as well as divalent metal (e.g. zinc, 
manganese) concentrations are regulated by astrocytes in the brain. Recently, it has been reported that cultured 
rat primary astrocytes exposed to Mn displayed decreased glutamate uptake, thereby, increasing the excitotoxic 
potential of glutamate. Since the neurotoxic mechanism(s) Mn employs in terms of glutamate metabolism is 
unknown, a primary goal of this study was to link altered glutamate uptake in Mn exposed astrocytes to 
alterations in glutamate transporter message. Further, we wanted to examine the gene expression of 
metallothionein (MT) and taurine transporter (tau-T) as markers of Mn exposure. Glutamate uptake was 
decreased by nearly 40% in accordance with a 48% decrease in glutamate/aspartate transporter (GLAST) 
mRNA. Taurine uptake was unaffected by Mn exposure even though tau-T mRNA increased by 123%. MT 
mRNA decreased in these Mn exposed astrocytes possibly due to altered metal metabolism, although this was 
not examined. These data show that glutamate and taurine transport in Mn exposed astrocytes are temporally 
different.  
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Article: 
INTRODUCTION 
Manganese (Mn) is an essential nutrient and is important for cellular functioning. However, excess Mn is 
known to cause neurotoxicity. Manganese has been implicated in oxidative stress (Stokes et al., 2000; DeSole et 
al., 1997), as well as disturbance of neurotransmitter metabolism (Miele et al., 2000; Montes et al., 2001). Few 
reports exist on brain [Mn] levels upon manganese intoxication. A study performed almost three decades ago, 
examined [Mn] in striatum and globus pallidus (two regions known to accumulate Mn) of monkeys dosed for 3 
months with manganese dioxide (Suzuki et al., 1975). Striatal [Mn] reached 264 μM, while globus pallidus 
[Mn] peaked at 334 μM. In rats, after Mn dosing, [Mn] can reach up to 200 μM depending upon brain region 
examined and dosing regimen (Ingersoll et al., 1999; Lai et al., 1999 and Roels et al., 1997). Thus, during 
manganese toxicity, it is possible for brain levels to exceed 350 μM. 
 
It has also been shown that Mn neurotoxicity may be due to an indirect excitotoxic event caused by altered 
glutamate metabolism (Brouillet et al., 1993). In the brain, both Mn uptake (Aschner et al., 1992) and 
glutamate uptake predominantly occur in astrocytes. In fact, it has been suggested that glutamate uptake by 
astrocytes, its conversion to glutamine via glutamine synthetase and deamination to glutamate is the primary 
glutamate recycling pathway (Van den Berg and Garfinkel, 1971; Westergaard et al., 1995; Ottersen et al., 
1992). Therefore, an attenuation of this pathway could be detrimental to neurons dependent on this astrocytic 
function. 
 
It has been estimated that 80% of glutamate is in astrocytes (Aschner et al., 2001) and that abnormally increased 
extracellular glutamate levels are excitotoxic to neurons (Choi, 1988). Therefore, it is critical that astrocytes are 
equipped with mechanism(s) for the rapid removal of glutamate from synaptic clefts. This uptake process 
occurs via sodium/potassium-dependent membrane proteins known as glutamate transporters. While there are 
several glutamate transporters known to be important for neuronal functioning, glutamate transporter and 
glutamate/aspartate transporter (GLAST) are the prominent astrocytic transporters (Danbolt, 2001). 
 
In cultured rat astrocytes, GLAST is the most prevalent glutamate transporter (Kondo et al., 1995), 
intracellularly transporting both glutamate and aspartate. A previous study showed that overnight Mn exposure 
to cultured rat astrocytes caused a 30% decrease in glutamate uptake (Hazell and Norenberg, 1997). It can be 
inferred from this study that Mn increases the excitotoxic potential as a result of increased extracellular 
glutamate. While it is speculated that decreased glutamate uptake is due to altered transporter functioning, 
levels of glutamate transporter protein and/or mRNA have not been examined in astrocytes exposed to Mn. 
Excess Mn is associated with neurotoxicity, thought to be due to oxidative stress (Stokes et al., 2000; DeSole et 
al., 1997). Like other eukaryotic cells, astrocytes possess defense mechanisms against increased intracellular 
oxidant levels. Amongst these is the sequestration of oxidants by metallothionein (MT). In CNS, MT exists in 
three isoforms (MT-I, MT-II and MT-III). MT-I and MT-II are expressed predominately in astrocytes, whereas 
MT-III is expressed primarily in hippocampal cells (Aschner, 1996). MT is important for cellular metabolism of 
metals, particularly in the brain where neural tissue is sensitive to any changes. Normally, zinc and copper 
levels will determine MT expression, (i.e. increased intracellular zinc levels leads to increased MT expression). 
While Mn intoxication in rats has been shown to have no effect on MT-I gene expression in striatal tissue 
(Zheng et al., 1999), it has yet to be determined whether astrocytic MT-I expression changes upon exposure to 
Mn. 
 
Taurine is an amino acid that has been implicated as a neuroprotectant. Its osmoregulatory release from 
astrocytes exemplifies its neuroprotective property (Vitarella et al., 1994). Taurine uptake is mediated by a 
sodium-dependent uptake mechanism via the taurine transporter (tau-T) (Martin, 1992). Both gene expression 
of tau-T (Bitoun and Tappaz, 2000) and taurine uptake (Aschner et al., 2001) are increased in astrocytes 
exposed to a hyperosmotic condition. Currently, both taurine uptake and tau-T gene expression in astrocytes 
exposed to Mn are unknown. 
 
Given the critical role of astrocytes in maintaining the composition of the extracellular fluid, the goals of this 
study were (1) to link altered glutamate uptake in Mn exposed cultured astrocytes to alterations in trans-porter 
metabolism (GLAST mRNA levels) and (2) to examine the gene expression of MT-I and tau-T as markers of 
Mn exposure. 
 
MATERIALS AND METHODS  
Cell Cultures 
Primary astrocyte cultures were prepared as described by Frangakis and Kimelberg (1984). Briefly, the cerebral 
hemispheres of newborn Sprague-Dawley rats were removed and meninges were carefully dissected off. The 
basal ganglia and midbrain were removed and the remaining cortical tissue dissociated with Dispase (Life 
Technologies, Gaithersburg, MD). Cells were grown in minimal essential medium (MEM), supplemented with 
10% horse serum (AGM). The cultures were maintained in a humidified atmosphere of 95% air/5% CO2 at 37 
°C. The media was changed twice weekly. 
3
H-aspartic acid uptake experiments and northern blots were 
performed after 3 weeks in culture, when the cells have formed a confluent monolayer. Immunocyto- 
chemically, >95% of the cells stained positively for the astrocytic marker glial fibrillary acidic protein (GFAP). 
Cell viability was measured by the trypan blue exclusion method (50% (v/v) of 0.4% staining solution). 
 
3
H-Aspartic Acid and 
3
H-Taurine Uptake 
Uptake of [2,3 ,-
3
H]-D-aspartate and [1,2, -
3
H] taurine were measured as described by Aschner et al. (1993). D-
Aspartate is a non-metabolizable glutamate analogue that shares the same transporter as glutamate (Drejer et al., 
1982). Astrocytes (grown on six well plates for 3–4 weeks) were incubated overnight at 37°C with AGM 
containing 0, 100, 250 or 500 μM MnCl2. The next day, cells were washed 3 times with HEPES buffer and 
incubated 1 min with HEPES buffer containing 0.5 μCi [2,3,-
3
H]-D-aspartate. The reaction was stopped by 
aspirating the buffer and washing the cells 4 times with cold (4°C) 290 mM mannitol buffer, containing 0.5 mM 
calcium nitrate to maintain cell adhesion to the substrate. Cells were solubilized in 2 ml 1 M NaOH, and 
aliquots (750 μl) were neutralized for 0-counting with a Beckman LS 3801 liquid scintillation analyzer 
(Beckman Instruments) and for protein determination (50 μl) with the bicinchonic assay (BCA, Pierce 
Chemicals). 
 
Northern Blot 
Following an overnight (18 h) exposure to 0, 100, 250 or 500 μM MnCl, the total RNA was isolated from 
astrocyte cultures with a monophase phenol and guanidine isothiocyanate solution (RNAStat-60, Tel-Test 
Laboratories, Friendswood, TX). RNA (10 μg) was separated by denaturing agarose electrophoresis and 
transferred to nitrocellulose membranes (Nytran SuPerCharge, Schleicher and Schuell, Keene, NH) by capillary 
action in 10 x SSC overnight. Membranes were cross-linked with an ultraviolet cross-linker to immobilize 
RNA. Each blot was probed for MT, GLAST and taurine transporter (tau-T). 
 
Blots were pre-hybridized in ultrasensitive hybridization buffer (Ambion Inc., Austin, TX) at 45°C (MT) or 
50°C (GLAST and tau-T) for 1 h, followed by overnight hybridization with approximately 10
6
 cpm/ ml of 
[alpha-
32
P] dCTP-labeled random primed cDNA probe (RadPrime DNA Labeling System, GibcoBRL, Life 
Technologies). GLAST cDNA probe was obtained from (Dr. Michael B. Robinson, University of 
Pennsylvania), MT cDNA probe from (Dr. Robert Andersen, University of California, Los Angeles) and 
Taurine Transporter cDNA was made according to Smith et al., 1992. Membranes were washed 2–3 times in 2x 
SSC/ 0. 1% SDS at 45°C (MT) or 50°C (GLAST and tau-T) for 20 min. Membranes were exposed to Kodak 
Bio-max MR film, at —80°C with intensifying screens for 2–3 days. The autoradiograms were quantified by 
densitometry scanning in conjunction with the TINA v2.09e computer program (Raytest USA Inc., Wilmington, 
NC). To correct for total RNA level, the blots were stripped in 0. 1 x SSC/0. 1 % SDS/40 mM Tris buffer and 
probed for 28s rRNA in 50% de-ionized formamide, 5 x Denhardt’s solution, 10% dextran sulfate, 0. 1 % SDS, 
4 x SSC, 100 μg/ml salmon sperm DNA, 20 mM Tris, pH 8.0 as described by Barbu and Dautry, 1989 to 
determine relative levels of the MT, GLAST and tau-T mRNAs. Films were digitized and band density was 
determined using the Tina v2.09e computer program (Raytest USA Inc., Wilmington, NC). 
 
Statistical Analyses 
All experiments were conducted in five astrocyte preparations 1–2 replicates each (northern analysis), or 3–6 
replicates each (uptake experiments). The data were analyzed with the GraphPad InStat version 3.02 for 
Windows, (GraphPad Software, San Diego, CA). One-way analysis of variance was carried out to test for 
concentration-dependent effects. Dunnet’s procedure was used to evaluate mean differences compared to 
control (0 μM MnCl2 treatment). The alpha level for the analyses was set at P < 0:05. 
 
RESULTS 
3
H-Aspartic Acid and 
3
H-Taurine Uptake 
Overnight incubation with medium containing both 250 and 500 μM MnCl2 significantly decreased the 1 min 
3
H-aspartate uptake in astrocytes by 24 and 38%, respectively, (P = 0:041) (Fig. 1) compared to control (0 μM 
MnCl2). However, no concentration of MnCl2 affected astrocyte 
3
H-taurine uptake (P = 0:54) (Fig. 2). 
 
Northern Analysis 
Exposure to 500 μM MnCl2 for 18 h significantly decreased astrocytic GLAST mRNA (48%; P = 0:037) (Fig. 
3) and MT mRNA (55%; P = 0:012) (Fig. 4) and increased tau-T mRNA (124%; P = 0:008) (Fig. 5) compared 
to control. All three mRNAs changed with 100 and 250 μM MnCl2 exposure, however, these changes were not 
significantly different from the control astrocyte mRNA expression levels. 
 
 
 
 
 
 
 
 
DISCUSSION 
This study demonstrates variable responses in astrocyte gene expression and amino acid uptake in response to 
potentially toxic concentrations of Mn. Exposure to 500 μM MnCl2 led to decreased mRNA levels of GLAST 
and MT, but the same concentration of manganese increased tau-T mRNA levels. Furthermore, aspartate uptake 
was significantly attenuated in Mn exposed astrocytes (250 and 500 μM) (Fig. 1), whereas, taurine uptake 
remained unchanged (Fig. 2). Both taurine uptake and tau-T mRNA data demonstrate that changes in aspartate 
uptake and GLAST, MT mRNA are specific to Mn exposure and not frank cytotoxicity. 
 
The decreased uptake of D-aspartate by astrocytes exposed to Mn corroborates an earlier study by Hazell and 
Norenberg (1997). Since astrocytes take up about 80% of extracellular glutamate (Aschner et al., 2001), any 
decrease in this uptake process can have profound neurotoxicological implications. Therefore, the 
excitotoxicant effect of increased extracellular glutamate associated with Mn-induced uptake inhibition, might 
represent a neurotoxic mechanism of manganese (Stokes et al., 2000; DeSole et al., 1997; Miele et al., 2000; 
Montes et al., 200 1). Most literature on Mn neurotoxicity and neurotransmitter metabolism focuses on 
alterations in the dopamine system (Verity, 1999). However, this study lends credence to the possibility of 
alterations in the glutamatergic system, as well as Y-amino butyric acid (GABA) systems, particularly in 
striatum where cortical glutamatergic afferents converge. Altered glutamatergic and GABAergic functioning 
can contribute to altered striatal dopamine metabolism (Page et al., 2001; Castro and Zigmond, 2001). 
Therefore, the neurotoxic effects of Mn on striatal dopamine may be indirectly mediated via abnormal striatal 
glutamate and/or GABA metabolism. 
 
GLAST is the most prevalent glutamate transporter in cultured astrocytes (Kondo et al., 1995). It is, there-fore, 
probable that the decreased glutamate uptake observed in Mn-exposed astrocytes represents decreased GLAST 
expression. Glutamate transporter are rapidly synthesized, and a cytosolic pool of these proteins is available for 
plasma membrane insertion as functional proteins in response to changes in extra-cellular glutamate levels 
(Davis et al., 1998). Decreased glutamate uptake observed in Mn-exposed astrocytes is, therefore, potentially 
due to decreased functional GLASTs. While the protein levels of GLAST were not measured in the present 
study, mRNA levels were indicative of decreased message due to manganese treatment (Fig. 3), potentially 
leading to decreased protein levels as well. 
 
MT is important for normal cellular homeostasis including gene regulation, adaptation to stress and metal 
metabolism (Cherian et al., 1997; Dunn et al., 1987; Durnam and Palmiter, 1987). MT-I gene expression 
increases in response to elevated intracellular zinc as well as other divalent metals (Katakai et al., 2001). 
Thus, it was quite unexpected to note decreased MT-I expression in Mn-treated astrocytes (Fig. 4). A number of 
explanations can account for this effect. First, increased intracellular [Mn] might diminish the con-tent of other 
divalent metals (e.g. zinc, copper) thereby exerting feedback inhibition, and decreasing MT mRNA expression. 
This is consistent with a recent report that decreased hepatic copper levels are associated with reduced MT-I 
expression (Aoyama et al., 2001). To date, it is unknown what, if any, effect Mn has on the metabolism of other 
metals in astrocytes. However, in the brain, increased Mn has been proven to interfere with divalent metal 
metabolism (Zheng et al., 1999). A second potential explanation is that decreased expression of MT-I mRNA 
upon Mn exposure is not associated with changes in functional MT protein levels, which have not been 
measured in the present study. 
 
Our study shows that astrocytes, exposed to Mn, have varying amino acid uptake capacities. This differential 
effect is evidenced by a decline in glutamate but not taurine uptake. When linking uptake of these amino acids 
to their respective transporters, the decreased glutamate uptake is congruent with GLAST expression. However, 
the unchanged taurine uptake is in contrast to the significant increase in tau-T mRNA (Fig. 5). One explanation 
of this inconsistency is that the 18 h exposure time to manganese was adequate for tau-T transcription, but not 
translation. Alternatively, the tau-T transporter protein may be present in these cells, but incorporation into the 
membrane is altered (i.e. decreased functional trans-porter). Protein kinase C (PKC) has been implicated in 
regulating tau-T, with increased PKC activity (increased phosphorylation) causing decreased taurine uptake in 
astrocytes (Tchoumkeu-Nzouessa and Rebel, 1996) and retinal cells (Loo et al., 1996). Unfortunately, no data 
are available on the effect of Mn on PKC activity, and the possibility that PKC regulates tau-T expression will 
have to await additional studies. Similarly, data on Mn-induced tau-T expression are lacking. 
 
It has been reported that hyperosmotic medium increases tau-T mRNA levels in astrocytes (Bitoun and Tappaz, 
2000). However, it is unlikely that Mn is causing a hyperosmotic condition in the experiments presented herein. 
Therefore, a more plausible explanation of our data is that the astrocytes are ―gearing up‖ for increased taurine 
transport, but that the time frame used in this study was too short to measure a change in  the functional capacity 
of tau-T. Indeed, we previously observed this phenomena in ethanol treated astrocytes where 24 h exposure did 
not effect taurine uptake, but 96 h exposure increased its uptake (Aschner et al., 2001). Taken collectively, these 
data support the fact that taurine and glutamate transport in astrocytes are temporally different. 
 
In conclusion, our data indicate that decreased glutamate uptake due to Mn exposure in astrocytes is linked to 
decreased GLAST mRNA. The experiments also support the hypothesis that manganese exposure might lead to 
exaggerated excitotoxic response due to diminished glutamate uptake by astrocytes. Further-more, the 
decreased MT-I mRNA and increased tau-T mRNA demonstrate a differential response by astrocytes to Mn 
exposure. Future studies will focus on measuring MT and tau-T protein levels and their role in Mn 
neurotoxicity. 
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